The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
HealthAI Companions Raises $260M Series C to Transform Healthcare
HealthAI Companions secures $260M in Series C funding at $3.4B valuation to scale ai companion deployment, advance predictive health analytics, and expand insurance partnerships.
BioIntelliSense secures $45M Series B for healthcare innovation
BioIntelliSense raises $45M in Series B funding to advance its continuous health monitoring platform using wearable biosensors and accelerate market growth.
Well secures $55M Series C for healthcare innovation
Well raises $55M in Series C funding to advance its telehealth platform providing virtual primary care services and accelerate market growth.
Linus Health secures $55M Series B for healthcare innovation
Linus Health raises $55M in Series B funding to advance its digital brain health assessment platform and accelerate market growth.
HealthAI Diagnostics raises $210M Series B in September 2025 funding round
HealthAI Diagnostics secures $210M in Series B funding in September 2025, reaching $2.1B valuation to advance its ai-powered medical imaging and diagnostic platform.
TeleHealth Plus raises $130M Series B in September 2025 funding round
TeleHealth Plus secures $130M in Series B funding in September 2025, reaching $1.1B valuation to advance its comprehensive telehealth platform with ai-powered diagnostics.
TeleHealth Global Secures $650M Series D to Lead Telemedicine Innovation
TeleHealth Global raises $650M in Series D funding at $9.1B valuation to expand to 100 countries, enhance ai diagnostic capabilities, and integrate with major healthcare systems globally.
NanoMedicine Labs Raises $460M Series C to Transform Healthcare
NanoMedicine Labs secures $460M in Series C funding at $5.8B valuation to advance phase iii clinical trials, scale manufacturing capabilities, and expand pipeline to rare diseases.
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.